Luca Maccioni

Luca Maccioni

Auto-generated profile, based on publicly available information

Luca Maccioni

Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BMBryan Mackowiak
Bryan Mackowiak
YFYaojie Fu
Yaojie Fu
LMLuca Maccioni
Luca Maccioni
BGBin Gao
Bin Gao
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.

20 June 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
YFYaojie Fu
Yaojie Fu
BMBryan Mackowiak
Bryan Mackowiak
YLYu-Hong Lin
Yu-Hong Lin
LMLuca Maccioni
Luca Maccioni
TLTaylor Lehner
Taylor Lehner
BGBin Gao
Bin Gao

12 April 2024 in Hepatology
Verified
Journal Article
Closed access
YFYaojie Fu
Yaojie Fu
LMLuca Maccioni
Luca Maccioni
XWXin Wei Wang
Xin Wei Wang
TGTim F. Greten
Tim F. Greten
BGBin Gao
Bin Gao
Heavy alcohol intake induces a wide spectrum of liver diseases ranging from steatosis, steatohepatitis, cirrhosis, and HCC. Although alcohol consumption is a well-known risk factor for the development, morbidity, and mortality of HCC globally, alcohol-associated hepatocellular carcinoma (A-HCC) is poorly characterized compared to viral hepatitis–associated HCC. Most A-HCCs develop after alcohol-associated cirrhosis (AC), but the direct carcinogenesis from ethanol and its metabolites to A-HCC remains obscure. The differences between A-HCC and HCCs caused by other etiologies have not been well investigated in terms of clinical prognosis, genetic or epigenetic landscape, molecular mechanisms, and heterogeneity. Moreover, there is a huge gap between basic research and clinical practice due to the lack of preclinical models of A-HCC. In the current review, we discuss the pathogenesis, heterogeneity, preclinical approaches, epigenetic, and genetic profiles of A-HCC, and discuss the current insights into and the prospects for future research on A-HCC. The potential effect of alcohol on cholangiocarcinoma and liver metastasis is also discussed.

7 April 2025 in eGastroenterology
Verified
Journal Article
Open access
PDF file
DFDechun Feng
Dechun Feng
YGYukun Guan
Yukun Guan
YWYang Wang
Yang Wang
LMLuca Maccioni
Luca Maccioni
BMBryan Mackowiak
Bryan Mackowiak
BGBin Gao
Bin Gao
Background: Healthy livers contain a large number of resident macrophages named Kupffer cells (KCs), which are partially replaced by infiltrating monocyte-derived macrophages (MoMFs) during acute or chronic liver injury. Despite extensive research, understanding macrophage heterogeneity, spatial distribution and interactions with other cells within the liver remains challenging. Methods: This study employs sequential multiplex immunofluorescence staining, advanced image analysis and single-cell RNA sequencing (scRNA-seq) analysis to characterise macrophages in both healthy and diseased livers in mice. Results: Our data revealed that liver KCs made up more than 80% of total immune cells in healthy mouse livers, while massive amounts of MoMFs infiltrated into the livers after acute and chronic liver injury. KCs were more abundant and larger in Zones 1 and 2 compared with Zone 3 in healthy livers. Zone 1 KCs exhibited higher phagocytic activity than Zone 2/3 KCs and MoMFs. We simultaneously evaluated cell proliferation and apoptosis on one slide and found that proliferation and apoptosis of KCs and MoMFs significantly increased in acutely injured livers. We also performed scRNA-seq to investigate liver macrophage gene expression in naïve and concanavalin A (ConA)-treated mice. MoMF clusters expanded following ConA treatment, while KCs remained stable. Macrophages were divided into distinct subtypes, including C1q+ MoMFs, with differential expression of genes like Trem2, Spp1, Fabp5 and Gpnmb. Newly recruited C1q− MoMFs expressed high levels of Lyz and Ccr2, while Itgax (Cd11c)+ MoMFs expressed endothelin converting enzyme 1 (Ece1), a gene encoding ECE1 enzyme that activates endothelin to promote hepatic stellate cell contraction and necrotic lesion resolution. By immunostaining analysis of the proteins encoded by these signature genes, we identified several populations of MoMFs that were mainly located surrounding the necrotic lesion area and expressed various proteins that are involved in dead cell debris clearance. Conclusion: We developed a robust framework for studying liver macrophages in vivo, offering insights into their roles in host defence and liver injury/repair. We identified several populations of MoMFs that surround necrotic lesion areas and express proteins that promote dead cell debris clearance. These necrotic lesion-associated macrophages likely play key roles in promoting necrotic lesion resolution.

22 December 2024 in eGastroenterology
Verified
Journal Article
Open access
PDF file
YGYukun Guan
Yukun Guan
DFDechun Feng
Dechun Feng
LMLuca Maccioni
Luca Maccioni
YWYang Wang
Yang Wang
BGBin Gao
Bin Gao
Alcohol-associated liver disease (ALD) is one of the leading chronic liver diseases worldwide, encompassing a spectrum of conditions from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma.1 Histologically, alcohol-associated steatohepatitis (ASH) is characterised by lipid accumulation in hepatocytes, hepatocellular damage, ballooning of hepatocytes, formation of Mallory-Denk bodies, inflammation and pericellular fibrosis.1 Over the past several decades, research has elucidated key molecular mechanisms underlying ALD, such as ethanol-induced hepatotoxicity, oxidative stress, endoplasmic reticulum stress and organ–organ crosstalk pathways like the gut-liver and adipose tissue-liver axes.2 Patients with underlying chronic ALD, particularly those with recent episodes of excessive drinking, are at risk of developing acute alcohol-associated hepatitis (AH), a condition characterised by severe clinical symptoms, including jaundice.3 Severe AH (sAH) is commonly linked to alcohol-associated cirrhosis (AC) and carries a high short-term mortality rate. Due to the limited availability of effective pharmacological therapies, early liver transplantation is frequently required as a life-saving intervention.3 Identifying molecular mechanisms driving AH progression and liver failure is thus essential for developing targeted therapies for this life-threatening disease. AH, first described in 1961, is recognised as an acute inflammatory liver disease characterised by extensive inflammatory cell infiltration.4 Currently, AH is recognised as a form of acute-on-chronic liver injury involving various types of immune cells, including macrophages, neutrophils, T cells and B cells, as evidenced by immunohistochemical analysis.5 Recent RNA-sequencing analyses have highlighted that AH is associated with the upregulation of numerous inflammatory mediators, including pro-inflammatory cytokines, chemokines and adhesion molecules.5–7 However, the key mechanisms that drive the transition from ALD to sAH remain unclear.

8 April 2025 in Gut
Verified
Journal Article
Closed access
LMLuca Maccioni
Luca Maccioni
YGYukun Guan
Yukun Guan
MKMariia Kim
Mariia Kim
MPMaria A Parra
Maria A Parra
BPBrandon Peiffer
Brandon Peiffer
BGBin Gao
Bin Gao
Background: Gut-liver crosstalk plays an important role in alcohol-associated liver disease (ALD) pathogenesis; but underlying mechanisms remain obscure. Objective: We examined the regulation of intestinal and intrahepatic CD8 + T lymphocytes and their contribution to ALD. Design: ALD patients were recruited for evaluation of intestinal and liver T cells. Single-cell RNA sequencing (scRNA seq) was performed to analyse intrahepatic and peripheral T cells in ALD. Wildtype, CD8-specific Bcl2 transgenic ( Cd8 Bcl-2 ), and Cd8 −/− mice were subjected to chronic-plus-binge ethanol feeding. Results: In ALD patients, duodenal CD8 + T cells were selectively reduced and negatively correlated with liver injury and bacterial translocation markers, while intrahepatic CD8 + T cells were markedly increased. ScRNA seq analysis of ALD patient livers revealed several populations of CD8 + T cells expressing activation and survival genes (eg, Bcl2 ). Transcriptomics and functional studies revealed a key role of prosurvival BCL2 in this opposite regulation of CD8 + T cells. Mechanistically, chronic-plus-binge ethanol feeding reduced CD8 + T cells specifically in the duodenum where ethanol levels are high. Inducing BCL2 in CD8 + T cells reversed ethanol-induced loss of duodenal CD8 + T cells, improved gut barrier function and ameliorated ALD, while CD8 deficiency was linked to enhanced neutrophil and macrophage infiltration in the liver, exacerbating ALD in mice. Conclusions: ALD is associated with loss of duodenal CD8 + T cells but elevation of intrahepatic CD8 + T cells, which aggravates and ameliorates ALD, respectively. Restoration of survival and functions of intestinal and intrahepatic CD8 + T cells may represent a novel therapeutic strategy for ALD patients.